AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/ 10.31579/2768-0487/011
*Corresponding Author: Şule Gökçe, Ege University Faculty of Medicine, Department of Pediatrics, General Pediatrics Unit. Ege University, Bornova, 35040, Izmir, Turkey.
Citation: Ş Gökçe, F Koç, C Çiçek, H Mehdiyeva, A Aslan. (2021) Influenza infections during the period of 2019–2020 -just before the COVID-19 outbreak- in a single unit. Journal of Clinical and Laboratory Research. 2(2) DOI: 10.31579/2768-0487/011
Copyright: ©2021 Şule Gökçe. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 25 February 2021 | Accepted: 02 April 2021 | Published: 06 April 2021
Keywords: ınfluenza; ınfluenza infections; children; clinical characteristics; immunization
Background and Purpose: We aimed to evaluate the demographic features, clinical manifestations, course of disease, and outcome of children with Influenza and Influenza complications.
Methods: In the winter season -just before the COVID 19 outbreak- between October 2019 and March 2020, the cases with Influenza diagnosed by rt-PCR (real time polymerase chain reaction) requiring hospitalization retrospectively were evaluated with hospital records.
Results: A total 36 children were hospitalized with Influenza virus infection. The most frequent presentations of the subjects were malaise and fever. Other clinical presentations consisted of vomitting (36.1%), abdominal pain (30.5%), myalgia (27.7%), diarrhea (25%), dry cough (19.4%), and arthralgia (11.1%). There were respiratory distress in 19 patients (52.7%) in our cohort. The most frequent underlying disease requiring hospitalization was neurological diseases.
Conclusions and Recommendation: The Influenza infection was associated with a wide variety of clinical findings during the hospital admission in pediatric patients. Immunization programs for Influenza should be considered for all children aged > 6 months, and should be also targeted the pediatric population that likely to be hospitalized with predisposing medical conditions- particularly neurological- every influenza season. Encouraging the use of Influenza vaccines will provide a decrease in Influenza that have similar presentations of COVID-19.
Influenza (flu) is an acute respiratory tract disease caused by Influenza viruses A and B (Inf A and B), and is generally responsible for outbreaks and epidemics worldwide in the winter seasons. The disease is a contagious disease that usually characterized by an acute onset upper airway tract symptoms including fever, cough, rhinitis, headache, myalgia in a healthy person. However, there have been many reports mentioning the association between flu and morbidity/mortality, especially in children, the elderly, pregnant women, health workers, and those with serious medical conditions. According to estimates of the World Health Organization (WHO), the virus effects the people as 16–28% in preschool-aged children, as 34–43% in school-aged children, and 5-10% of adults every winter season [1, 2]. Despite the fact that the Influenza infections generally cause an uncomplicated disease, some pediatric patients might become severely ill, to the point of hospitalization or even death; particularly having a neurological condition, immunosuppression, an abnormal chest radiograph, and moderate persistent asthma [3, 4]. In order to prevent complications and deaths, the Influenza vaccine in pediatric age from 6 months to 5 years has been recommended by the WHO.
There are four types of Influenza viruses including A, B, C and D; seasonal influenza viruses (Inf A and B) that spread from person to person, through contact with respiratory secretions or contaminated objects are responsible for outbreaks each year. Inf A viruses are further classified into subtypes according to the proteins known as the combinations of hemagglutinin (HA) and the neuraminidase (NA) on the surface of the virus. The subtype A/H1N1 and A/H3N2 Influenza viruses had been circulating since the 1900s, and the last efficacious (written as A(H1N1)pdm09) outbreak of the respiratory tract disease was first noticed in Mexico. It has been declared by the WHO as a pandemic illness originated from A/H1N1 in June 2009 [1].
The classic symptoms of simple influenza virus infection include abrupt onset of fever, headache, myalgia, accompanied by features of respiratory-tract illness, such as cough, sore throat, and rhinitis [5, 6]. The presence of multiplex polymerase chain reaction (PCR) has provided a permitting simultaneous amplification of the viruses and allowed to examine the epidemiological differences/clinical characteristics of the viruses [7]. Due to the fact that the economic burden of Influenza effects the health services and the insurance and legal systems; many studies have been focusing for many years on Influenza virus and its outbreaks to determine the behavior; for prevention and treatment strategies against it.
This study aimed to analyze the epidemiological and clinical features as well as laboratory findings and outcome of children admitted to a tertiary pediatric hospital during the period of 2019-2020 winter season with confirmed Influenza virus infection. The index study also purposed to detect whether there were any differences between Inf A and B in the presentation, hospital course, and outcome of pediatric patients.
Study Design and Period: This retrospective, cross-sectional, observational study has evaluated the patients (aged from 2 months-18 years) diagnosed with Influenza or been thought a preliminary diagnosis of Influenza at the Ege University Medical Faculty General Pediatrics ward of Children’s Hospital between October 2019 and March 2020. This study was approved by the ethics committee of Ege University and the institutional review board of Ege University Children’s Hospital (20-9T/39).
The Detection of Influenza viruses: A nasal smear was obtained from each patient and transported to the laboratory in a viral universal transport medium (Copan Diagnostics, Brescia, Italy). The extraction of nucleic acids was performed on a fully automated device with EZ1 Virus Mini Kit v2 (Qiagen, Luxembourg) according to the manufacturer’s recommendations. Influenza viruses were identified by real-time polymerase chain reaction method (RealAccurate, Respiratory RT PCR, PathoFinder, Netherlands, and Seeplex RV15 ACE Detection, Seegene, South Korea) using FTD Respiratory pathogens 21 ov kit (Fast Track Diagnosis, Luxembourg) and the results were obtained from the RotorGene (Qiagen, Luxembourg) device.
Patients: A structured case report form was filled by the physician from the parents of children with influenza infection for clinical, epidemiological, and laboratory data. The case report forms have covered the data such as gender, age, pre-existing chronic disease, date of symptom onset and date of hospital admission, complications (pneumonia, acute respiratory distress syndrome, multiorgan failure, and septic shock), antiviral treatment received, seasonal Influenza vaccination status, and laboratory data included confirmed virus type, and several biochemical analyze results.
Statistical analyses: Data analyses were performed using SPSS version 21.0. The quantitative data including percentage, mean, and standard deviations were calculated by simple descriptive analyses. Shapiro-Wilk test was used to check normality and according to the results parametric or nonparametric suitable statistical tests were performed. Differences in the distribution of categorical parameters were analyzed by χ2 or Fisher's Exact Test. An independent samples T-test or nonparametric alternative of its Mann-Whitney U test was used to compare 2 groups for a quantitative variable. The differences between Influenza subtypes were assessed and a P-value of <0 .05 was considered to be significant.c
Patients: During the winter season between October 2019-March 2020, a total of 440 patients have been hospitalized for any disease at General Pediatrics Unit. Thirty-six (8.1%) cases with Influenza requiring hospitalization were evaluated in the study. Of the 36 hospitalized cases, 77.7% (28 patients) tested positive for Inf A virus and 22.3% (8 patients) for Inf B. The most frequent A subtypes were H1N1 (66.7%); H3N2 was accounted as 4 patients (11.1%). Table 1 has shown the demographic, clinical and presenting features of children with Influenza. Of the total, 55.6% were male, 44.4% were female. The median length of hospital stay was 4 days (3) in children with Influenza viruses. The most common presentations on admission were: malaise in 31 (86.1%), fever in 30 (83.3%), and sore throat in 15 (41.6%) cases.
Laboratory and Clinical follow-up: Table 2 has shown the treatment modalities, hematological findings, complications, and other features of the subjects. Oseltamivir was administered in 16 (44.4%) children. A total of 9 (25%) children were given antibiotics together with antiviral drugs. 44.4% received antiviral treatment with oseltamivir, of whom 56.3% received it within 48 hours after symptom onset. The median time between symptom onset and hospital admission was 3 (2) days. The most frequent complication was lower respiratory tract infection (LRTI) 19 (52.7%), of whom one patient diagnosed with acute respiratory distress syndrome (5.2%) and of whom 3 patients needed mechanical ventilation. The median white blood cell count was 7.5 (8.9)/mm3; the median absolute neutrophil count was 3.4 (5.9)/mm3; neutrophile count as <1500/mm3 was seen in 10 (27.8%) patients. Creatine kinase was measured in 13/36 children, with the mean value of 1894 (max: 12.367; min: 19) U/L; of whom six cases were diagnosed with myositis. Two patients with Inf A; 1 patient with Inf B (8.3%) cases required pediatric intensive care unit. In terms of the chronic conditions and predisposing factors; at least one underlying medical condition was detected for 13 (43%) of the 36 children; neurological disorders were the most frequent condition in our study cohort (n = 5, 38.4% of all 13 children with predisposing factors).
Clinic and demographical differences (Table 3): The cases of Inf A were younger (P > 0.05). No differences were found according to sex (P > 0.05). There was no difference in the frequency of the gastrointestinal symptoms of nausea and/or vomiting with either Inf A or B. Among the Inf A group, 2 patients presented with a febrile seizure. With regard to other presentations; 5 cases with myositis have admitted to our clinic in Inf A group, 2 in the Inf B group. There were also no significant differences in the symptoms and other features according to virus type.
The study has shown the clinical manifestations of Influenza infections among hospitalized children with PCR-confirmed Influenza in the period of October 2019-March 2020 in the General Pediatrics ward of Children’s Hospital. The most prevalent type of Influenza in children was Inf A (77.7%); it was more common than Inf B/ non-H1N1 (22.3%). With regard to the age distribution, Inf A was younger than those with Inf B. It has been reported that age could be a significant differential factor by Livia Mancinelli et al [8]; when they analyzed the virus Inf A was more common in children less than 12 months, and Inf B was more prevalent in school-age. Similarly, a study conducted from Canada stated that a patient with Influenza under 12 months of age that results in a 2.3 times required the hospitalization [9]. Another study has reported that the Inf A (H1N1) pdm09 subtype was more common and was associated with severe clinical features in children aged <2 years; however, Inf B infection was more frequently seen in older ages [10]. It was found that hospitalized children were generally preschool-aged, with a median age of around 25 months. Influenza A subtype was more common in subjects aged under 24 months (63.1%), of whom needed intensive care unit and mechanical ventilation. The children >5 years (median 83 months) infected with Influenza B were more frequent in this study. In contrast, a study conducted from the USA showed that the median age of pediatric patients hospitalized with Influenza A were 6.5 years, whereas; this age in Inf B was 1.3 years [11].
As reported previously, Influenza virus infection is most common in previously healthy children with fever and nonspecific upper airway tract signs and symptoms that are similar to those of other infectious processes in hospitalized children. In the study population, the clinical course was mostly self-limited with malaise (86.1%), fever (83.3%), and sore throat (41.6%) as predominant symptoms. In literature, malaise and fever are the most prominent manifestation and gastrointestinal symptoms were found to be more prevelant in Inf A/H1N1 than other influenza types [11]. Although there was no significant association to a certain Influenza strain; compitable with the literature, our subjects with Inf A presented with gastrointestinal symptoms like vomiting and diarrhea were more common than those Inf B. No consistent differences were observed in the other clinical presentation of patients by viral subtype in the study. The risk of complications has been reported in 25% to 49% in the children with underlying diseases [12]. Neurological disorders were the most common disease referring principal risk factor accounting for 38.4% of all Influenza positive cases with several diseases.
It was found that Influenza infected patients had higher rates of LRTI (19/36 cases), as observed in other studies. Mireia Jane et al [10] have evaluated a total of 291 patients; 62.2% of cases had pneumonia, 26.8% acute respiratory distress syndrome, and 11.7% bacterial pneumonia during the Inf A and B infection. A retrospective observational study was conducted in 360 cases of whom 39.7% of patients suffered from LRTI; pneumonia and acute respiratory failure [13]. The children hospitalized with laboratory-confirmed A/H1N1 were reviewed by A. Desiree LaBeaud [14]; of the 47 severe cases, 34 required oxygen, 20 required intubation, 7 had acute respiratory distress syndrome and 23 cases with pneumonia. Many patients with Influenza A/H1N1 manifested with gastroenteritis without respiratory symptoms and they required hospitalization due to dehydration and inability to feed in our study. So, it might be easily declared that the clinicians should also consider the Influenza infections presenting gastrointestinal symptoms in the setting of the Influenza season. In the laboratory, it has been found statistically insignificant lower absolute neutrophil counts, particularly in children infected with Inf B compared with Inf A/non-H1N1 in this study. A research stated by Ching-Fen Shen et al [15] have reported that the lower leucocyte counts in pediatric patients with Inf B compared with Inf A/non-H1N1 and decreased leukocytes might be used criteria for the diagnosis of Inf B infection before viral culture results.
There has been recommended by the World Health Organization and Centers for Disease Control and Prevention (CDC) that children should be vaccinated between 6 months and 5 years to help avoid hospital admissions for Influenza. There is also a recommendation for children between 6 months and three years of age the implementing the booster dose [16]. On February 11, 2020, the World Health Organization officially described a pandemic novel virus named Coronavirus disease 2019 (COVID-19), and the International Committee on Taxonomy of Viruses has called it severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2). The clinical manifestations of Novel coronavirus infection consist of fever, cough, myalgia, and/or fatigue. Due to the fact that the possibility of Influenza viruses and COVID-19 virus share the same season and have quite similar manifestations, there is an anxiousness whether to be accurately identified these two respiratory viral infections. Although it has been reported that there were many differences in clinical presentations such as lower severity illness scores at presentation and mortality in sufferer with A/H1N1 compared with those infected with COVID-19, it is thought to be difficult to differentiate these two diseases upcoming winter [17].
Potential limitations can be listed:
the study may not reflect incidence of actual Influenza due to only patients with laboratory-confirmed Influenza,
unable to collect information about the clinical cases in patients admitted to the outpatient clinic and emergency department and
finally, fairly small study size may also have restricted the identification of significant relations with the disease predictors and severity.
In this study– just before the declarations of COVID-19 pandemic – we have described that the clinical features of children with Influenza during the 2019–2020 season and defined whether there was differences. Pediatric patients were presented with quite a variety of clinical findings. The neurological disorder has over again been confirmed as the most significant and prevelant risk factor for Influenza infection in children. It should not to be neglected the vaccination against Influenza for all children, especially children with a history of chronic conditions. There could be a vigorous possibility that the children could have a co-infection (Influenza and COVID-19) and we have never known this co-existance. Encouraging the use of Influenza vaccines will provide a decrease in Influenza infection that have similar presentations of COVID-19.
The author(s) declared no potential conflicts of interests with respect to the authorship and/or publication of this article.
ŞG: conceived of the study, and participated in its design and coordination and drafted the manuscript. ŞG and FK: participated in the design of the study, and collection and acquisition of data. FK: helped to the design of the study, collection and acquisition of data, and helped to draft the manuscript. ŞG: general supervision of the research group, coordination and helped to draft the manuscript. CÇ: carried out molecular analysis. ŞG: performed the statistical analysis. All authors read and approved the final manuscrip.
The author(s) received no financial support for the research and/or authorship of this article.
The study was approved by the institutional review board named The Ethics Committee of Ege University (20-9T/39).
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
